The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy

Breast cancer metastatic to bone has a poor prognosis despite recent advances in our understanding of the biology of both bone and breast cancer. This article presents a new approach, the ABC7 regimen (Adjuvant for Breast Cancer treatment using seven repurposed drugs), to metastatic breast cancer. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kast, Richard E, Skuli, Nicolas, Cos, Samuel, Karpel-Massler, Georg, Shiozawa, Yusuke, Goshen, Ran, Halatsch, Marc-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513700/
https://www.ncbi.nlm.nih.gov/pubmed/28744157
http://dx.doi.org/10.2147/BCTT.S139963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513700/
https://www.ncbi.nlm.nih.gov/pubmed/28744157
http://dx.doi.org/10.2147/BCTT.S139963

Ejemplares similares